Karolinska Development AB ser. B Total Liabilities
Karolinska Development AB ser. B total liabilities. Based on the latest financial reports, Karolinska Development AB ser. B (KDEV) has total liabilities worth Skr6.55 Million SEK (≈ $704.78K USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check KDEV financial resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Karolinska Development AB ser. B (2007–2025)
Total liabilities of Karolinska Development AB ser. B from 2007 to 2025. This chart illustrates how Karolinska Development AB ser. B's total liabilities have evolved over time, based on quarterly financial data. Explore Karolinska Development AB ser. B long-term investment intensity to see how much of total assets are deployed in long-term investments.
Karolinska Development AB ser. B Competitors by Total Liabilities
The table below lists competitors of Karolinska Development AB ser. B ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
DarioHealth Corp
NASDAQ:DRIO
|
USA | $41.50 Million |
|
Klimasan Klima Sanayi ve Ticaret AS
IS:KLMSN
|
Turkey | TL5.97 Billion |
|
Klondike Gold Corp
V:KG
|
Canada | CA$179.72K |
|
Taya Inv-L
TA:TAYA
|
Israel | ILA31.93 Million |
|
Tamul Multimedia Co. Ltd
KQ:093640
|
Korea | ₩32.86 Billion |
|
Artea SA
PA:ARTE
|
France | €236.12 Million |
|
WIZIT Co. Ltd
KQ:036090
|
Korea | ₩273.85 Billion |
|
Bubang Co. Ltd
KQ:014470
|
Korea | ₩81.19 Billion |
Liability Composition Analysis (2007–2025)
This chart breaks down Karolinska Development AB ser. B's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is Karolinska Development AB ser. B's balance sheet.
Liquidity & Leverage Metrics
Karolinska Development AB ser. B Total Liabilities Ratios Explained
Karolinska Development AB ser. B total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 128.29 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.01 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.01 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Karolinska Development AB ser. B's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Karolinska Development AB ser. B (2007–2025)
The table below shows the annual total liabilities of Karolinska Development AB ser. B from 2007 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr8.34 Million ≈ $897.73K |
-37.07% |
| 2024-12-31 | Skr13.26 Million ≈ $1.43 Million |
+14.59% |
| 2023-12-31 | Skr11.57 Million ≈ $1.25 Million |
+13.33% |
| 2022-12-31 | Skr10.21 Million ≈ $1.10 Million |
-92.61% |
| 2021-12-31 | Skr138.19 Million ≈ $14.87 Million |
+53.86% |
| 2020-12-31 | Skr89.82 Million ≈ $9.67 Million |
-43.50% |
| 2019-12-31 | Skr158.97 Million ≈ $17.11 Million |
-68.10% |
| 2018-12-31 | Skr498.38 Million ≈ $53.63 Million |
+25.81% |
| 2017-12-31 | Skr396.14 Million ≈ $42.63 Million |
-3.03% |
| 2016-12-31 | Skr408.50 Million ≈ $43.96 Million |
+11.44% |
| 2015-12-31 | Skr366.58 Million ≈ $39.45 Million |
+465.50% |
| 2014-12-31 | Skr64.82 Million ≈ $6.98 Million |
+155.46% |
| 2013-12-31 | Skr25.38 Million ≈ $2.73 Million |
-86.70% |
| 2012-12-31 | Skr190.81 Million ≈ $20.53 Million |
+10.98% |
| 2011-12-31 | Skr171.93 Million ≈ $18.50 Million |
+204.56% |
| 2010-12-31 | Skr56.45 Million ≈ $6.08 Million |
+40.33% |
| 2009-12-31 | Skr40.23 Million ≈ $4.33 Million |
+204.40% |
| 2008-12-31 | Skr13.22 Million ≈ $1.42 Million |
-79.92% |
| 2007-12-31 | Skr65.83 Million ≈ $7.08 Million |
-- |
About Karolinska Development AB ser. B
KDventures AB is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, medical innovations, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in th… Read more